Hexagon Bio

Vortex Biosciences, Inc. is a Menlo Park-based company that is developing a groundbreaking liquid biopsy technology for cancer diagnosis, monitoring, and treatment. Led by experienced professionals in the diagnostics, medical devices, and pharmaceutical industries, Vortex Biosciences aims to revolutionize the field of cancer research with their innovative products and solutions. The company's team, including CTO Paul Reeves and Technology Advisor Colin Toombs, brings extensive expertise in product development, regulatory approvals, and commercial success. With a focus on genomics, translational clinical research, and advanced analytics, Vortex Biosciences is dedicated to delivering innovative technologies that have the potential to transform cancer care.Generated from the website

Protagonist Therapeutics, based in Menlo Park, is a pioneering biotechnology company that has developed ReCode, the first genetic medicines platform designed for precise delivery to organs, tissues, and cells outside of the liver. The company's pipeline of rare disease therapeutics utilizes optimized mRNA and gene correction technologies with the unique ability for redosing, offering innovative solutions for addressing unmet medical needs in the field of genetic medicine. Generated from their website's infomation

Dice Molecules Corporation, based in Menlo Park, is a pioneering company founded by industry veterans dedicated to advancing immunology and small molecule discovery. Their mission is to develop convenient oral medicines with biologic-like efficacy for patients suffering from chronic diseases. With a vision of a future where innovative treatments are accessible to all, Dice Molecules Corporation is at the forefront of revolutionizing the pharmaceutical landscape. Through their expertise and passion, they strive to make a significant impact on the lives of those in need of effective therapies. Generated from their website's infomation